Health Care & Life Sciences » Biotechnology | Shandong Sinobioway Biomedicine Co. Ltd.

Shandong Sinobioway Biomedicine Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
314
316
854
1,255
1,152
656
Cost of Goods Sold (COGS) incl. D&A
179
192
158
320
273
140
Gross Income
135
124
697
935
879
516
SG&A Expense
41
39
420
511
493
524
EBIT
94
84
271
433
385
7
Unusual Expense
-
-
-
-
10
163
Non Operating Income/Expense
1
1
1
6
11
6
Interest Expense
-
-
17
5
15
81
Pretax Income
103
96
269
434
391
210
Income Tax
15
14
42
40
73
9
Equity in Affiliates
-
-
13
22
74
127
Consolidated Net Income
88
81
240
417
392
93
Net Income
88
81
250
418
388
96
Net Income After Extraordinaries
88
81
250
418
388
96
Net Income Available to Common
88
81
250
418
388
96
EPS (Basic)
0.32
0.29
0.56
0.63
0.59
0.15
Basic Shares Outstanding
282
282
447
660
660
660
EPS (Diluted)
0.31
0.29
0.56
0.63
0.59
0.15
Diluted Shares Outstanding
282
282
447
660
660
660
EBITDA
101
96
315
490
439
55
Other Operating Expense
-
1
1
5
9
-
Non-Operating Interest Income
9
11
8
11
21
33
Minority Interest Expense
-
-
10
1
4
3

About Shandong Sinobioway Biomedicine Co.

View Profile
Address
Peking University Biological City
Beijing Shandong 100085
China
Employees -
Website http://www.sdsinobioway.com
Updated 07/08/2019
Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. Its products include pharmaceutical intermediates and pesticide intermediates. The company was founded on January 18, 2000 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.